Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
734 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003804 | Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor | unknown | Phase 3 | 350 | University of LeicesterOTHER | 15 | Jun 24, 2014 | clinicaltrials |
| NCT00030719 | Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma | unknown | Phase 3 | 175 | University of LeicesterOTHER | 13 | Jun 24, 2014 |
| clinicaltrials |
| NCT00053872 | Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma | unknown | Phase 3 | 316 | University of LeicesterOTHER | 8 | Jun 24, 2014 | clinicaltrials |
| NCT00038467 | Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer(IES) | completed | Phase 3 | 4,740 | PfizerINDUSTRY | 37 | May 7, 2014 | clinicaltrials |
| NCT01229436 | Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex)(POINT X) | completed | Phase 3 | 254 | PfizerINDUSTRY | 8 | Mar 17, 2014 | clinicaltrials |
| NCT00086580 | Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients | completed | Phase 3 | 335 | Genzyme, a Sanofi CompanyINDUSTRY | 15 | Mar 13, 2014 | clinicaltrials |
| NCT00015873 | Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia | completed | Phase 3 | 350 | Dutch Childhood Oncology GroupOTHER | 11 | Feb 17, 2014 | clinicaltrials |
| NCT00989131 | Study of Paclitaxel in Patients With Ovarian Cancer | completed | Phase 3 | 789 | Oasmia Pharmaceutical ABINDUSTRY | 16 | Feb 4, 2014 | clinicaltrials |
| NCT00058201 | Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | completed | Phase 3 | 1,030 | Royal Liverpool University HospitalOTHER_GOV | 13 | Dec 18, 2013 | clinicaltrials |
| NCT01101399 | Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy(FID-CHEMO) | completed | Phase 3 | 19 | Vifor PharmaINDUSTRY | 2 | Dec 18, 2013 | clinicaltrials |
| NCT00262067 | A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1) | unknown | Phase 3 | 1,237 | Genentech, Inc.INDUSTRY | 22 | Dec 13, 2013 | clinicaltrials |
| NCT00025428 | Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma | completed | Phase 3 | 100 | Societe Internationale d'Oncologie PediatriqueOTHER | 12 | Dec 4, 2013 | clinicaltrials |
| NCT00474786 | Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib(INTORSECT) | completed | Phase 3 | 512 | PfizerINDUSTRY | 20 | Nov 21, 2013 | clinicaltrials |
| NCT00884273 | Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients | completed | Phase 3 | 182 | Ferring PharmaceuticalsINDUSTRY | 8 | Nov 13, 2013 | clinicaltrials |
| NCT00003991 | Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia | completed | Phase 3 | 360 | Maxim PharmaceuticalsINDUSTRY | 12 | Nov 6, 2013 | clinicaltrials |
| NCT00017095 | Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer | completed | Phase 3 | 1,856 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Oct 24, 2013 | clinicaltrials |
| NCT00382031 | Zalutumumab in Patients With Non-curable Head and Neck Cancer | completed | Phase 3 | 286 | GenmabINDUSTRY | 12 | Oct 15, 2013 | clinicaltrials |
| NCT00333840 | Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia | completed | Phase 3 | 1,106 | Novartis PharmaceuticalsINDUSTRY | 16 | Oct 14, 2013 | clinicaltrials |
| NCT00003771 | Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer | completed | Phase 3 | 1,300 | Regional Oncologic CenterOTHER | 5 | Sep 20, 2013 | clinicaltrials |
| NCT00005589 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | completed | Phase 3 | 460 | EBMT Solid Tumors Working PartyOTHER | 17 | Sep 17, 2013 | clinicaltrials |
| NCT00376792 | Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer | unknown | Phase 3 | 396 | Scandinavian Prostate Cancer GroupNETWORK | 5 | Aug 26, 2013 | clinicaltrials |
| NCT00753688 | Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy(PALETTE) | completed | Phase 3 | 369 | GlaxoSmithKlineINDUSTRY | 13 | Aug 22, 2013 | clinicaltrials |
| NCT00334854 | Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma | unknown | Phase 3 | 250 | European Paediatric Soft Tissue Sarcoma Study GroupOTHER | 9 | Aug 12, 2013 | clinicaltrials |
| NCT00379457 | Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma | unknown | Phase 3 | 600 | European Paediatric Soft Tissue Sarcoma Study GroupOTHER | 8 | Aug 12, 2013 | clinicaltrials |
| NCT00690430 | Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease | completed | Phase 3 | 186 | Novartis PharmaceuticalsINDUSTRY | 16 | Jul 30, 2013 | clinicaltrials |
| NCT00255606 | Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer | completed | Phase 3 | 360 | Tampere UniversityOTHER | 3 | Jun 26, 2013 | clinicaltrials |
| NCT00598156 | Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- Tarceva(ACT) | completed | Phase 3 | 249 | Lund University HospitalOTHER | 2 | Apr 22, 2013 | clinicaltrials |
| NCT00002528 | Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer(10-93) | completed | Phase 3 | 473 | ETOP IBCSG Partners FoundationNETWORK | 9 | Apr 4, 2013 | clinicaltrials |
| NCT00002529 | Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer(12-93) | completed | Phase 3 | 452 | ETOP IBCSG Partners FoundationNETWORK | 7 | Apr 4, 2013 | clinicaltrials |
| NCT00002823 | Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 3 | 3,300 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 29 | Mar 28, 2013 | clinicaltrials |
| NCT00676650 | Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy(SUN 1120) | terminated | Phase 3 | 873 | PfizerINDUSTRY | 22 | Mar 8, 2013 | clinicaltrials |
| NCT00694382 | Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy(SAVE-ONCO) | completed | Phase 3 | 3,212 | SanofiINDUSTRY | 49 | Jan 23, 2013 | clinicaltrials |
| NCT00699374 | Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer | terminated | Phase 3 | 1,075 | PfizerINDUSTRY | 23 | Jan 14, 2013 | clinicaltrials |
| NCT00967018 | A Long Term Safety Study of Degarelix in Patients With Prostate Cancer | completed | Phase 3 | 77 | Ferring PharmaceuticalsINDUSTRY | 7 | Jan 3, 2013 | clinicaltrials |
| NCT00065468 | Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma(ARCC) | completed | Phase 3 | 626 | PfizerINDUSTRY | 25 | Oct 25, 2012 | clinicaltrials |
| NCT00991744 | Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL) | suspended | Phase 3 | 100 | Nordic Society for Pediatric Hematology and OncologyOTHER | 5 | Oct 10, 2012 | clinicaltrials |
| NCT00561470 | Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen(VELOUR) | completed | Phase 3 | 1,226 | SanofiINDUSTRY | 28 | Sep 28, 2012 | clinicaltrials |
| NCT00002459 | Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus | completed | Phase 3 | 224 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Sep 24, 2012 | clinicaltrials |
| NCT00003938 | Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients | completed | Phase 3 | 115 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 15 | Sep 24, 2012 | clinicaltrials |
| NCT00617669 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer(ENTHUSE M1C) | completed | Phase 3 | 1,494 | AstraZenecaINDUSTRY | 26 | Sep 10, 2012 | clinicaltrials |
| NCT00033904 | Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer | completed | Phase 3 | 650 | Agenus Inc.INDUSTRY | 11 | Sep 7, 2012 | clinicaltrials |
| NCT00039000 | Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma | completed | Phase 3 | 350 | Agenus Inc.INDUSTRY | 9 | Sep 7, 2012 | clinicaltrials |
| NCT00626548 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer(ENTHUSE M0) | terminated | Phase 3 | 2,577 | AstraZenecaINDUSTRY | 39 | Sep 3, 2012 | clinicaltrials |
| NCT00256698 | Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy(FACT) | completed | Phase 3 | 514 | AstraZenecaINDUSTRY | 12 | Aug 1, 2012 | clinicaltrials |
| NCT00393939 | Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer(SUN 1064) | completed | Phase 3 | 594 | PfizerINDUSTRY | 27 | Jul 19, 2012 | clinicaltrials |
| NCT00471146 | Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. | completed | Phase 3 | 630 | PfizerINDUSTRY | 24 | Jul 16, 2012 | clinicaltrials |
| NCT00002764 | Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | completed | Phase 3 | 340 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00002840 | Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma | completed | Phase 3 | 350 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Jul 10, 2012 | clinicaltrials |
| NCT00257205 | CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy | completed | Phase 3 | 655 | AstraZenecaINDUSTRY | 21 | Jul 2, 2012 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials